Administration of growth hormone to animals has been found to reduce fat stores (1, 2), to increase liver fat (3, 4) and to cause ketosis (5) and a depression of respiratory quotient (6, 7). The increase in mobilization and metabolism of fat implied by these findings has been thought to contribute either in an auxiliary or in an essential way to the anabolic stimulus induced by growth hormone.
per L. in one hour and the value remained low during the six hour infusion (Figure 2) . A fall in concentration of variable magnitude was observed without glucose in dogs anesthetized with pentobarbital, but the depressant effect of glucose was much greater than that obtained with anesthesia alone. In a similar experiment, but with insulin as well as glucose in the infusion medium, the value again fell despite prior growth hormone administration, but large doses of epinephrine, 0.2 mg. and 0.25 mg. given 10 minutes apart intravenously, caused a rapid rise in fatty acids despite the continued infusion. Fatty acids rose from 250 jEq. per L. to 1,220 JLEq. per L. 30 minutes after the first injection. Growth hormone differed from epinephrine, which had previously been shown to elevate fatty acids (8, 9) , in producing a slower response and a more sustained rise after a single injection and in the complete suppression of its effect by glucose.
Alloxan diabetic dogs were more sensitive than normal dogs to the effect of growth hormone. The difference in sensitivity was more apparent when sampling was performed seven hours after the daily meal rather than after a 24 hour fast. Growth hormone administered four hours before the determination greatly increased the values in diabetic dogs but affected normal dogs only slightly. In this experiment growth hormone elevated the values before a spontaneous postabsorptive rise occurred, suggesting that food suppresses the growth hormone effect less effectively in the diabetic dog.
The diabetic dogs responded to the smallest doses of purified growth hormone preparations used, 0.03 mg. per Kg. Fatty acid values in dogs were increased with purified preparations of porcine, bovine, human and simian growth hormone in contrast to the values in man which were affected only by the human and simian materials. The responsiveness of dogs to human growth hormone appeared to diminish over some weeks with repeated injections, whereas human subjects showed no loss in sensitivity over much longer periods.
Studies in man
The fasting value of plasma fatty acids in man was increased within four hours by the injection of human growth hormone. Fasting samples were obtained between 8:00 and 10:00 a.m.; the test substance was then administered intramuscularly and another blood sample was obtained four hours after the injection.
In the first group of 11 tests in five subjects, the average plasma fatty acid value rose from 555 pEq. Figure 3 . The time of maximal effect was not established but was probably longer than four hours. Four mg. of human growth hormone raised the value for at least 24 hours in hypopituitary subjects, but usually for less than this period in normal subjects.
Three subjects, two normal adult males and an elderly hypopituitary male, were tested repeatedly over a six month period. The four hour change in fatty acids exceeded 400 fAEq. per L. in 16 or 18 trials with hormone and in none of 14 trials without hormone (Figure 4) . The minimal effective dose in the normal subjects was approximately 1.0 and 2.0 mg., while the hypopituitary subject had a substantial response from 0.5 mg., the smallest dose used. Other hypopituitary subjects were also found to be more sensitive than normal individuals, and some normal subjects required larger doses for a definite effect than the subjects of Figure 4 .
As in the dog, glucose and food abolished the fatty acid response to growth hormone. Figure 5 illustrates Simian growth hormone was also active in man but porcine and bovine preparations were inert. All values four hours after 3 to 8 mg. of human growth hormone and after 4 to 20 mg. of simian growth hormone exceeded 1,000 puEq. per L. and all values on control days or after other pituitary preparations were below this figure (Figure 6 ). These included values after 20 to 30 mg. of porcine and 30 mg. of bovine growth hormone, 10 units of Thyrotropar®, 25 mg. of lactogenic hormone, and 50 to 400 clinical units of porcine and human corticotropin.
Larger effects might have been expected with corticotropin which was shown by Rosenberg (14) to increase liver fat in the mouse, and by White and Engel ( 15) and by Astwood ( 16) to stimulate fatty acid release from rat adipose tissue when added in vitro. The small response to corticotropin was apparently not due to adrenal stimulation, since cortisone neither lowered the fatty acid value nor inhibited the response to growth hormone.
In the subjects tested repeatedly over a six month period no loss in responsiveness to human growth hormone was observed and the material was invariably well tolerated. Most subjects noted no subjective effects, but three reported an increased libido and an obese woman on a 400 calorie diet reported a diminution in appetite when receiving human growth hormone (5.0 mg. per day). Blood sugar values were not affected in these tests.
Human growth hormone prepared by the acetic acid extraction method is virtually free of other known anterior and posterior lobe hormones, and thus its adipokinetic effect must be due to growth hormone or to a yet unidentified factor present in the preparation. The specificity of the human response to human and simian preparations noted in this study is compatible with other evidence of growth hormone behavior in man. Porcine and bovine preparations have appeared active only occasionally in many metabolic balance and growth studies. Human preparations have been regularly active and simian hormone, though less extensively tested, has appeared to be active in metabolic balance studies (20) (21) (22) (23) (24) . The fatty acid response may indeed provide a rapid test for the effectiveness of growth hormone preparations in man (25) . DISCUSSION' The small doses of human growth hormone needed to elevate plasma fatty acids suggest a physiological role for this hormone in fat mobilization as well as in growth. Indeed, if corrected for body weight, the dose necessary for fatty acid elevation may be smaller than that required for growth, although little information is as yet available as to the amount needed for growth in man (17) . 
